title: No evidence that pyrazinamide resistance is acquired after fluoroquinolone resistance.
authors.affiliation: KNCV Tuberculosis Foundation, The Hague, The Netherlands; Amsterdam Institute for Global Health and Development, Academic Medical Center, Amsterdam, The Netherlands.
authors.forename: Frank
authors.initials: F
authors.lastname: Cobelens
authors.affiliation: KNCV Tuberculosis Foundation, The Hague, The Netherlands.
authors.forename: Agnes
authors.initials: A
authors.lastname: Gebhard
authors.affiliation: KNCV Tuberculosis Foundation, The Hague, The Netherlands; Amsterdam Institute for Global Health and Development, Academic Medical Center, Amsterdam, The Netherlands.
authors.forename: Susan
authors.initials: S
authors.lastname: van den Hof
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use*; D024901:Drug Resistance, Multiple, Bacterial; D024841:Fluoroquinolones / Q000627:therapeutic use*; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D011718:Pyrazinamide / Q000627:therapeutic use*; D012293:Rifampin / Q000627:therapeutic use*; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy* / Q000382:microbiology*
chemical_list: D000995:Antitubercular Agents; D024841:Fluoroquinolones; D011718:Pyrazinamide; D012293:Rifampin